European journal of hospital pharmacy : science and practice最新文献

筛选
英文 中文
Antibiotic labels frozen in time: a barrier to effective antimicrobial stewardship? 抗生素标签及时冷冻:有效抗菌药物管理的障碍?
IF 1.5 4区 医学
European journal of hospital pharmacy : science and practice Pub Date : 2025-09-25 DOI: 10.1136/ejhpharm-2025-004760
Daniele Mengato, Xhoajda Taci, Elisabetta Mariavittoria Giunco, Samuele Gardin, Silvia Cavinato, Sonia Faoro, Umberto Gallo, Annamaria Cattelan, Francesca Venturini
{"title":"Antibiotic labels frozen in time: a barrier to effective antimicrobial stewardship?","authors":"Daniele Mengato, Xhoajda Taci, Elisabetta Mariavittoria Giunco, Samuele Gardin, Silvia Cavinato, Sonia Faoro, Umberto Gallo, Annamaria Cattelan, Francesca Venturini","doi":"10.1136/ejhpharm-2025-004760","DOIUrl":"https://doi.org/10.1136/ejhpharm-2025-004760","url":null,"abstract":"","PeriodicalId":12050,"journal":{"name":"European journal of hospital pharmacy : science and practice","volume":" ","pages":""},"PeriodicalIF":1.5,"publicationDate":"2025-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145148287","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Medication needs of children and young people for successful transition to adult services (the SUCCESS study): an exploratory cross-sectional observational study. 儿童和青少年成功过渡到成人服务的药物需求(SUCCESS研究):一项探索性横断面观察研究。
IF 1.5 4区 医学
European journal of hospital pharmacy : science and practice Pub Date : 2025-09-22 DOI: 10.1136/ejhpharm-2025-004528
Ashifa Trivedi, Sarah Mohamad, Merin Thoppil, Roshnee Patel, Shivani Sethi, Naiya Patel, Anne-Lise Goddings
{"title":"Medication needs of children and young people for successful transition to adult services (the SUCCESS study): an exploratory cross-sectional observational study.","authors":"Ashifa Trivedi, Sarah Mohamad, Merin Thoppil, Roshnee Patel, Shivani Sethi, Naiya Patel, Anne-Lise Goddings","doi":"10.1136/ejhpharm-2025-004528","DOIUrl":"https://doi.org/10.1136/ejhpharm-2025-004528","url":null,"abstract":"<p><strong>Objective: </strong>To explore the medication-related knowledge, behaviours and support needs of children and young people (YP) aged 11-16 years with long-term conditions as they prepare to transition from paediatric to adult healthcare services.</p><p><strong>Methods: </strong>This exploratory cross-sectional study was co-designed with YP living with chronic conditions, conducted at a district general hospital in Northwest London between April and September 2023. Participants were those aged 11-16 years admitted to the paediatric ward with long-term conditions requiring regular medication. YP self-completed a questionnaire on medication-related aspects of transition, including knowledge of medication names, dosages, reordering, side effects, adherence and their ability to manage medications independently.</p><p><strong>Results: </strong>Of 41 eligible YP, 30 completed the questionnaire (73% response rate). Most knew the names and dosages of their medications (24/30) and why they were prescribed (25/30). However, only half (15) knew how their medicines worked, and fewer (10) were aware of potential side effects. Just 12 participants knew how to reorder their medication. Fifteen reported missing doses, mostly due to forgetfulness. Most relied on parents or carers to manage medicines (23), with only four managing independently. YP reported healthcare professionals (17) and family (19) as their main sources of medication information.</p><p><strong>Conclusions: </strong>This study suggests that while YP often have good foundational medication knowledge, many lack the deeper understanding and practical skills required for independent self-management. Knowledge of side effects, reordering processes and shared decision-making was limited, areas which could undermine transition readiness if unaddressed. Pharmacists, working as part of the multidisciplinary team, are well placed to support YP through targeted, age-appropriate education and regular review.</p>","PeriodicalId":12050,"journal":{"name":"European journal of hospital pharmacy : science and practice","volume":" ","pages":""},"PeriodicalIF":1.5,"publicationDate":"2025-09-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145124409","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Critical role of persistence and adherence in multiple sclerosis treatment: the value of cladribine. 坚持和坚持在多发性硬化症治疗中的关键作用:克拉德里滨的价值。
IF 1.5 4区 医学
European journal of hospital pharmacy : science and practice Pub Date : 2025-09-22 DOI: 10.1136/ejhpharm-2025-004582
Joaquin Borrás Blasco, Vicente Merino-Bohorquez, Esther Ramírez Herráiz
{"title":"Critical role of persistence and adherence in multiple sclerosis treatment: the value of cladribine.","authors":"Joaquin Borrás Blasco, Vicente Merino-Bohorquez, Esther Ramírez Herráiz","doi":"10.1136/ejhpharm-2025-004582","DOIUrl":"10.1136/ejhpharm-2025-004582","url":null,"abstract":"","PeriodicalId":12050,"journal":{"name":"European journal of hospital pharmacy : science and practice","volume":" ","pages":""},"PeriodicalIF":1.5,"publicationDate":"2025-09-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144552769","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effectiveness and safety of off-label dupilumab use for the treatment of pemphigoid gestationis: a new case report. 标签外dupilumab用于治疗类天疱疮妊娠的有效性和安全性:一个新的病例报告。
IF 1.5 4区 医学
European journal of hospital pharmacy : science and practice Pub Date : 2025-09-17 DOI: 10.1136/ejhpharm-2025-004583
María Calvo Arbeloa, Amaya Arrondo Velasco, Paula Rodriguez Jimenez, Maite Sarobe Carricas
{"title":"Effectiveness and safety of off-label dupilumab use for the treatment of pemphigoid gestationis: a new case report.","authors":"María Calvo Arbeloa, Amaya Arrondo Velasco, Paula Rodriguez Jimenez, Maite Sarobe Carricas","doi":"10.1136/ejhpharm-2025-004583","DOIUrl":"https://doi.org/10.1136/ejhpharm-2025-004583","url":null,"abstract":"<p><p>Pemphigoid gestationis (PG) is a very rare autoimmune disorder that typically occurs during the second and third trimesters of pregnancy. It is characterised by intense pruritus, erythematous plaques and vesicles, primarily affecting the abdomen and extremities. The exact cause remains unclear, but type 2 inflammation and antibodies against the collagen protein BP180 are implicated. Diagnosis is confirmed through clinical findings and specific tests. Traditional treatments include topical and systemic corticosteroids, but they can have significant side effects.This case report discusses a 38-year-old woman with PG in her second pregnancy, who experienced the disorder in her first pregnancy with severe symptoms and was treated with corticosteroids and intravenous immunoglobulins but developed serious side effects. In her current pregnancy, dupilumab was introduced at week 30 (off-label use), leading to significant symptom improvement within a week.This case supports the potential of dupilumab as a first-line treatment for severe PG, demonstrating safety and efficacy for both mother and baby.</p>","PeriodicalId":12050,"journal":{"name":"European journal of hospital pharmacy : science and practice","volume":" ","pages":""},"PeriodicalIF":1.5,"publicationDate":"2025-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145080025","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ifosfamide-induced encephalopathy and concomitant use of netupitant/palonosetron in a patient with soft tissue sarcoma: a case report. 异环磷酰胺诱导的脑病和同时使用尼吡坦/帕洛诺司琼的软组织肉瘤患者:1例报告。
IF 1.5 4区 医学
European journal of hospital pharmacy : science and practice Pub Date : 2025-09-17 DOI: 10.1136/ejhpharm-2025-004493
Andrea Pinilla Rello, Rafael Huarte Lacunza, Antonio Tejada Artigas
{"title":"Ifosfamide-induced encephalopathy and concomitant use of netupitant/palonosetron in a patient with soft tissue sarcoma: a case report.","authors":"Andrea Pinilla Rello, Rafael Huarte Lacunza, Antonio Tejada Artigas","doi":"10.1136/ejhpharm-2025-004493","DOIUrl":"https://doi.org/10.1136/ejhpharm-2025-004493","url":null,"abstract":"<p><p>A woman in her 30s diagnosed with high-grade soft tissue sarcoma with pulmonary metastases began treatment with ifosfamide-epirubicin, netupitant/palonosetron and dexamethasone. Shortly after, she developed dizziness and dysarthria, raising suspicion of ifosfamide-induced encephalopathy. Ifosfamide was immediately discontinued before the first dose was completed, and treatment with methylene blue was initiated the following day as the clinical condition continued to worsen. Due to her clinical condition, she was transferred to the intensive care unit, where she was started on thiamine and dexmedetomidine combined with methylene blue. Three days later, her neurological status improved, allowing methylene blue and thiamine to be discontinued. Several publications have reported cases of ifosfamide-related encephalopathy in patients receiving concomitant aprepitant, a CYP3A4 substrate and inhibitor that may increase the levels of ifosfamide's toxic metabolites. However, no cases of ifosfamide-induced encephalopathy have been reported with the use of netupitant/palonosetron for antiemetic prophylaxis. In light of our patient's condition, it is possible that the concomitant use of ifosfamide and netupitant/palonosetron contributed to an earlier onset and increased severity of ifosfamide-related neurotoxicity.</p>","PeriodicalId":12050,"journal":{"name":"European journal of hospital pharmacy : science and practice","volume":" ","pages":""},"PeriodicalIF":1.5,"publicationDate":"2025-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145080004","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pharmacist-led stewardship standardised broad-spectrum antibiotic use in a geriatric-heavy neurology ward. 药师主导的管理标准化广谱抗生素的使用在老年重神经病学病房。
IF 1.5 4区 医学
European journal of hospital pharmacy : science and practice Pub Date : 2025-09-17 DOI: 10.1136/ejhpharm-2025-004630
Qinbo Chen, Li Zhang
{"title":"Pharmacist-led stewardship standardised broad-spectrum antibiotic use in a geriatric-heavy neurology ward.","authors":"Qinbo Chen, Li Zhang","doi":"10.1136/ejhpharm-2025-004630","DOIUrl":"https://doi.org/10.1136/ejhpharm-2025-004630","url":null,"abstract":"<p><strong>Objectives: </strong>To evaluate the impact of clinical pharmacist-led antibiotic stewardship on enhancing the rational use of antibiotics in a geriatric-heavy neurology ward.</p><p><strong>Methods: </strong>A retrospective analysis was conducted on all antibiotic-treated hospitalised cases during the study period, with a total of 123 patients. The study employed a consecutive enrolment design. Of these, 62 cases were managed under a pharmacist-led antibiotic stewardship programme as the intervention group, while the remaining 61 cases served as controls. Primary outcomes included hospitalisation stays, hospitalisation costs, antibiotic consumption, the duration of antibiotic use and the efficacy of antibiotic therapy.</p><p><strong>Results: </strong>The intervention group exhibited a lower number of defined daily doses (DDDs) per patient between their stay compared with the control group (13.18±1.25 DDDs vs 20.03±2.15 DDDs, p=0.007). Moreover, the duration of single antibiotic treatment was notably reduced in the intervention group (10.40±0.75 days vs 13.16±1.16 days, p=0.047), as was the duration of the single longest empirical therapy with broad-spectrum antibiotics (6.77±0.55 days vs 10.29±1.15 days, p=0.007).</p><p><strong>Conclusions: </strong>Pharmacist-led antibiotic stewardship effectively optimised antibiotic use in geriatric neurology patients, reducing unnecessary broad-spectrum antibiotic exposure and improving treatment efficiency.</p>","PeriodicalId":12050,"journal":{"name":"European journal of hospital pharmacy : science and practice","volume":" ","pages":""},"PeriodicalIF":1.5,"publicationDate":"2025-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145079399","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Moxifloxacin-induced insomnia with psychotic episodes in a toddler: a case report. 莫西沙星致失眠症伴幼儿精神病发作1例报告。
IF 1.5 4区 医学
European journal of hospital pharmacy : science and practice Pub Date : 2025-09-17 DOI: 10.1136/ejhpharm-2025-004600
Violeta Getova-Kolarova, Ines Hababa-Ivanova, Nicoleta Georgieva
{"title":"Moxifloxacin-induced insomnia with psychotic episodes in a toddler: a case report.","authors":"Violeta Getova-Kolarova, Ines Hababa-Ivanova, Nicoleta Georgieva","doi":"10.1136/ejhpharm-2025-004600","DOIUrl":"https://doi.org/10.1136/ejhpharm-2025-004600","url":null,"abstract":"<p><p>Moxifloxacin is a fourth-generation fluoroquinolone with a broad spectrum of antibacterial activity. It is commonly used for both local and systemic applications. Data on the safety profile of fluoroquinolones indicate the potential for serious adverse reactions including neurological and psychiatric disturbances. The current case describes the off-label use of moxifloxacin eye drops for nasal administration in a toddler which led to insomnia and symptoms of severe psychosis. Notably, these adverse events resolved completely shortly after discontinuation of treatment. This case highlights a rare and potentially debilitating adverse reaction and underscores the critical importance of clinical judgement when prescribing off-label medicines in the paediatric population.</p>","PeriodicalId":12050,"journal":{"name":"European journal of hospital pharmacy : science and practice","volume":" ","pages":""},"PeriodicalIF":1.5,"publicationDate":"2025-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145079974","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Unused medication among outpatients receiving cost-free medication from a community pharmacy in the Region of Southern Denmark. 在丹麦南部地区的一个社区药房接受免费药物的门诊病人中未使用的药物。
IF 1.5 4区 医学
European journal of hospital pharmacy : science and practice Pub Date : 2025-09-14 DOI: 10.1136/ejhpharm-2025-004615
Thomas Croft Buck, Mia Lolk Lund
{"title":"Unused medication among outpatients receiving cost-free medication from a community pharmacy in the Region of Southern Denmark.","authors":"Thomas Croft Buck, Mia Lolk Lund","doi":"10.1136/ejhpharm-2025-004615","DOIUrl":"https://doi.org/10.1136/ejhpharm-2025-004615","url":null,"abstract":"<p><strong>Objective: </strong>To evaluate the extent and nature of unused medication dispensed from the hospital as cost-free medication (CFM), sent to and collected from the community pharmacy (St Thomas Pharmacy) in the Region of Southern Denmark.</p><p><strong>Methods: </strong>This observational study was conducted over 6 months. In the first 2 months, patients collecting CFM were invited to participate in an unused medication monitoring programme by completing an inclusion questionnaire. Those who consented were followed for four additional months and asked to report on unused medication during subsequent visits. Data on dispensed medication and patient-reported unused medication were collected using structured survey forms and analysed using descriptive statistics.</p><p><strong>Results: </strong>Thirteen per cent of patients reported unused medication from approximately 100 enrolled participants. Collecting CFM for themselves, the unused medication rate was 15%, compared with 8% among those collecting on behalf of others. No unused medication was reported by first-time collectors. Reported reasons included clinical changes (eg, dose adjustments, treatment discontinuation, adverse effects) and administrative errors (eg, excess quantities, incorrect formulations). The total value of unused medication was estimated at 83 000 Kr (€11 100). Extrapolated to the annual distribution volume at the St Thomas Pharmacy, the annual loss from unused medication would be 900 000 Kr (€120 000).</p><p><strong>Conclusion: </strong>The small sample size in this project is a limitation and associated with an uncertain outcome. Unused medication related to CFM is a measurable and economically significant issue, primarily driven by clinical and administrative factors. While reducing pack sizes could help mitigate unused medication, this may increase logistical burdens on patients and healthcare providers. A larger distribution model, such as dispensing through all local community pharmacies under hospital tender agreements, may offer a more efficient solution but would require legislative reform. Broader, multi-site studies are needed to validate findings and inform future policy interventions.</p>","PeriodicalId":12050,"journal":{"name":"European journal of hospital pharmacy : science and practice","volume":" ","pages":""},"PeriodicalIF":1.5,"publicationDate":"2025-09-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145063777","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Enhancing depression management in older cancer patients: the pharmacist's role. 加强老年癌症患者的抑郁管理:药剂师的角色。
IF 1.5 4区 医学
European journal of hospital pharmacy : science and practice Pub Date : 2025-09-08 DOI: 10.1136/ejhpharm-2025-004682
Rojita Jadhari, Nabin Pathak, Shreya Dhungana, Ajaya Acharya, Sunil Shrestha
{"title":"Enhancing depression management in older cancer patients: the pharmacist's role.","authors":"Rojita Jadhari, Nabin Pathak, Shreya Dhungana, Ajaya Acharya, Sunil Shrestha","doi":"10.1136/ejhpharm-2025-004682","DOIUrl":"https://doi.org/10.1136/ejhpharm-2025-004682","url":null,"abstract":"","PeriodicalId":12050,"journal":{"name":"European journal of hospital pharmacy : science and practice","volume":" ","pages":""},"PeriodicalIF":1.5,"publicationDate":"2025-09-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145023063","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hospital pharmacists in cardio-oncology: bridging a critical gap in multidisciplinary cancer care. 心脏肿瘤学的医院药剂师:弥合多学科癌症护理的关键差距。
IF 1.5 4区 医学
European journal of hospital pharmacy : science and practice Pub Date : 2025-09-04 DOI: 10.1136/ejhpharm-2025-004698
Esteban Zavaleta-Monestel, Sebastian Arguedas-Chacon, Kevin Cruz-Mora, Jeaustin Mora-Jimenez
{"title":"Hospital pharmacists in cardio-oncology: bridging a critical gap in multidisciplinary cancer care.","authors":"Esteban Zavaleta-Monestel, Sebastian Arguedas-Chacon, Kevin Cruz-Mora, Jeaustin Mora-Jimenez","doi":"10.1136/ejhpharm-2025-004698","DOIUrl":"https://doi.org/10.1136/ejhpharm-2025-004698","url":null,"abstract":"","PeriodicalId":12050,"journal":{"name":"European journal of hospital pharmacy : science and practice","volume":" ","pages":""},"PeriodicalIF":1.5,"publicationDate":"2025-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144999995","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信